Pediatric topical steroid withdrawal syndrome: what is known, what is unknown
MDM2 and MDMX promote ferroptosis by PPARalpha-mediated lipid remodeling
Nutrapharm launches Setria-powered supplement, marking a regulatory milestone for the clinically researched ingredient in South America NEW YORK, June 11, 2026 /PRNewswire/ -- Kyowa Hakko, a global leader in health ingredient innovation and manufacturer of branded ingredient Setria Glutathione, today announced that a supplement featuring Setria has been approved for sale in Chile through the Secretara Regional Ministerial (SEREMI) de Salud
This results in oxidative stress which hinders not only the production of thyroid hormones, but also the conversion of T4 into the active T3 form used by cells
Lachovicz R, Ferro-Lebres V, Almeida-de-Souza J, Pereira JA